ARKG - Cathie Wood Can't Get Enough of These 2 Biotech Stocks
Almost every day, Ark Invest buys at least a handful of innovation-heavy stocks for its collection of exchange-traded funds. Ark Invest founder and CEO Cathie Wood has a lot of confidence in the genomic revolution, and in two companies in particular.
Hardly a day in March has gone by without Wood making purchases of Adaptive Biotechnologies (NASDAQ: ADPT) , Burning Rock Biotech (NASDAQ: BNR) , or both. Here's why she thinks they can generate big gains for the Ark Genomic Revolution ETF (NYSEMKT: ARKG) and individual investors.
Image source: Getty Images.
For further details see:
Cathie Wood Can't Get Enough of These 2 Biotech Stocks